company background image
524742

Caplin Point Laboratories BSE:524742 Stock Report

Last Price

₹692.45

Market Cap

₹52.5b

7D

0.6%

1Y

-16.2%

Updated

01 Feb, 2023

Data

Company Financials +

Caplin Point Laboratories Limited

BSE:524742 Stock Report

Mkt Cap: ₹52.5b

524742 Stock Overview

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India.

524742 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends5/6

My Notes

New

Notes are coming soon

Caplin Point Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Caplin Point Laboratories
Historical stock prices
Current Share Price₹692.45
52 Week High₹856.00
52 Week Low₹626.30
Beta0.41
1 Month Change-4.27%
3 Month Change-5.83%
1 Year Change-16.16%
3 Year Change112.47%
5 Year Change17.25%
Change since IPO314,650.00%

Recent News & Updates

Recent updates

Shareholder Returns

524742IN PharmaceuticalsIN Market
7D0.6%-1.8%-3.7%
1Y-16.2%-7.6%-2.2%

Return vs Industry: 524742 underperformed the Indian Pharmaceuticals industry which returned -7.6% over the past year.

Return vs Market: 524742 underperformed the Indian Market which returned -2.2% over the past year.

Price Volatility

Is 524742's price volatile compared to industry and market?
524742 volatility
524742 Average Weekly Movement3.3%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.7%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.3%

Stable Share Price: 524742 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 524742's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19903,000Sridhar Ganesanhttps://www.caplinpoint.net

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic droppers, prefilled bags, tablets, dry syrups, soft gels, capsules, suppositories, liquid syrups in bottles, liquid injectables in ampoules and vials, prefilled syringes, emulsion injection in ampoules and vials, topicals, and sachets. It also operates QueTenX, an e-commerce website.

Caplin Point Laboratories Limited Fundamentals Summary

How do Caplin Point Laboratories's earnings and revenue compare to its market cap?
524742 fundamental statistics
Market Cap₹52.49b
Earnings (TTM)₹3.31b
Revenue (TTM)₹13.72b

15.9x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
524742 income statement (TTM)
Revenue₹13.72b
Cost of Revenue₹6.33b
Gross Profit₹7.39b
Other Expenses₹4.08b
Earnings₹3.31b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 11, 2023

Earnings per share (EPS)43.57
Gross Margin53.85%
Net Profit Margin24.10%
Debt/Equity Ratio0.01%

How did 524742 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

5%

Payout Ratio